Head of Market Access
Bob is the Head of Market Access at Servier Pharmaceuticals. He is responsible for all aspects of market access including pricing strategy, government contracting, gross-to-net modeling, payer marketing, health economics and outcomes research (HEOR), real world evidence generation, the National Accounts and GPO teams, Trade and Distribution and specialty pharmacy. In his role, he collaborates with Medical Affairs, Corporate Strategy, Business Development, Patient Services, Global Value and Access, Finance and Public Affairs.
Bob has significant experience in U.S. and global pricing, market access, and HEOR and has held leadership positions in these areas at several life-science consulting companies. Bob has held sales and marketing positions at Johnson & Johnson, Purdue Pharma, and Bristol Myers Squibb. He has experience in launching dozens of biopharmaceutical products in numerous therapeutic areas with specific expertise in oncology, hematology and immunology. For over a decade, Bob was the Founder and President of Evolution Health Initiatives, an industry leading market access consulting and payer-communications company. As an industry thought leader, Bob has published several peer-reviewed studies in oncology clinical outcomes, pricing, market access and health economics. He has made numerous presentations in these areas at congresses in the U.S., Europe, and Asia.
Bob received his Bachelor of Science in Pharmacy from Rutgers University, where he currently lectures on global pricing and market access in the Pharmaceutical Management MBA program. He received his Master of Business Administration from Fairleigh Dickinson University.